Oral terbinafine for dermatophytosis among MSM: a report from EADV 2026
The congress report describes oral terbinafine for 8–12 weeks as first-line treatment for the reported dermatophytosis among men who have sex with men. The available excerpt provides no dose or efficacy data.
#terbinafine Le Quotidien du Médecin